BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19362305)

  • 1. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Diamond MP; Abuzeid M
    Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.
    Zarutskie PW; Phillips JA
    Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
    Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
    Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial.
    Unfer V; Casini ML; Gerli S; Costabile L; Mignosa M; Di Renzo GC
    Fertil Steril; 2004 Dec; 82(6):1509-13. PubMed ID: 15589851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
    Mochtar MH; Van Wely M; Van der Veen F
    Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J;
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C; Lindenberg S;
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer.
    Khan N; Richter KS; Newsome TL; Blake EJ; Yankov VI
    Fertil Steril; 2009 Jun; 91(6):2445-50. PubMed ID: 18555224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
    Doody KJ; Schnell VL; Foulk RA; Miller CE; Kolb BA; Blake EJ; Yankov VI
    Fertil Steril; 2009 Apr; 91(4):1012-7. PubMed ID: 18371963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial.
    Silverberg KM; Vaughn TC; Hansard LJ; Burger NZ; Minter T
    Fertil Steril; 2012 Feb; 97(2):344-8. PubMed ID: 22188983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles.
    Kyrou D; Fatemi HM; Popovic-Todorovic B; Van den Abbeel E; Camus M; Devroey P
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):175-9. PubMed ID: 20219279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial.
    Goudge CS; Nagel TC; Damario MA
    Fertil Steril; 2010 Aug; 94(3):946-51. PubMed ID: 19523613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles.
    Dovey S; McIntyre K; Jacobson D; Catov J; Wakim A
    Fertil Steril; 2011 Sep; 96(3):585-9. PubMed ID: 21774931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial.
    Kahraman S; Karagozoglu SH; Karlikaya G
    Fertil Steril; 2010 Jul; 94(2):761-3. PubMed ID: 19939363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.